Pharmacist | New Grad/Resident | Technician | Intern/Student | |
Member | $160 | $80 | $80 | $25 |
Non-Member | $240 | $160 | $160 | $80 |
Date: Oct 3, 2023 08:00 AM - 05:00 PM
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Co-Sponsor(s)
Requirements for CE Credit
Registration closes on Dec 03, 2023
at 01:00 AM
Registration Closed
- Summarize the history and structure of the Practice Advancement Initiative 2030 (PAI 2030)
- Demonstrate how the results of ASHP National Survey and 2023 Pharmacy Forecast support the targets of practice change outlined in PAI 2030
- Illustrate published PAI 2030 best practice case studies
- Demonstrate the resources available from ASHP to our individual practitioners, organizations, and our state affiliate to develop action plans related to PAI 2030
Speaker(s)/Author(s)
Jennifer Bair, PharmD, BCPS
|
Activity Number
0062-9999-23-139-L04-P/TCE Hours
Registration Closed
- Review the mechanism of action and approved indications for lecanemab, terlipressin, and Respiratory Syncytial Virus (RSV) vaccine and monoclonal antibody (mAb)
- Summarize lecanemab, terlipressin, and RSV vaccine and mAb place in therapy
- Describe health-system considerations for lecanemab, terlipressin, and RSV vaccine and mAb
- Recall the approved indications for lecanemab, terlipressin, and RSV vaccines and mAb
- Recognize pharmacy and care areas where lecanemab, terlipressin, and RSV vaccine and mAb are provided
- Describe health-system considerations for lecanemab, terlipressin, and RSV vaccine and mAb
Speaker(s)/Author(s)
Sarah Harrison, PharmD, BCCCP
|
Activity Number
0062-9999-23-140-L01-P/TCE Hours
Registration Closed
- Describe the epidemiology and pathophysiology of opioid use disorder (OUD)
- List current FDA approved medications for the treatment of OUD
- Discuss the pharmacology of buprenorphine
- Review alternatives to standard buprenorphine induction
- Apply acquired knowledge to a patient case
Speaker(s)/Author(s)
Sophie Robert, BPharm, PharmD, BCPP
|
Activity Number
0062-9999-23-141-L08-P/TCE Hours
Registration Closed
- Define the role of tele-antimicrobial stewardship as it applies to the Center for Diseases Control and Prevention (CDC) core elements of hospital stewardship
- Analyze current literature on tele-antimicrobial stewardship
- Identify strategies associated with incorporating stewardship programs in regional sites’ workflow
- Develop action plans for expansion to regional sites given various examples
- Outline the CDC core elements of tele-antimicrobial stewardship
- Discuss current literature regarding tele-antimicrobial stewardship
- Describe strategies associated with establishing antimicrobial stewardship in regional sites’ workflow
- Create action strategies to incorporate antimicrobial stewardship to regional sites given multiple examples
Speaker(s)/Author(s)
Aaron Hamby, PharmD, BCIDP
|
|
Erin Brewer, PharmD, BCPS
|
Activity Number
0062-9999-23-142-L04-P/TCE Hours
Registration Closed
- Describe pharmacist impact on commonly encountered clinical scenarios
- Provide an example of appropriate continuity of care for commonly encountered clinical scenarios
- Recognize medication safety principles in commonly encountered clinical scenarios
- Describe the importance of utilizing evidence-based medicine in commonly encountered clinical scenarios
Activity Number
0062-9999-23-143-L01-P/TCE Hours
Registration Closed
- Discuss the requirements of the South Carolina Pharmacy Access Act
- Compare the available hormonal contraception options including combined oral contraceptives, progestin only pill, rings, patches, and injections
- Apply the components of the Pharmacy Access Act to practice
- Determine an appropriate treatment option through a patient case
- Discuss the requirements of the South Carolina Pharmacy Access Act
- Identify the available hormonal contraception options including combined oral contraceptives, progestin only pill, rings, patches, and injections
- Apply the components of the Pharmacy Access Act to a patient case
Speaker(s)/Author(s)
Marissa Pettit, PharmD
|
Activity Number
0062-9999-23-144-L03-P/TCE Hours
Registration Closed
- Describe important risk factors for cancer-associated thrombosis
- Predict which patients with cancer would benefit from prophylaxis for prevention of cancer-associated thrombosis
- Summarize recent guideline updates for the management of cancer-associated thrombosis
- Select an appropriate regimen for treatment of cancer-associated thrombosis
- Discuss how the development of cancer-associated thrombosis may negatively affect prognosis
- List contraindications for use of prophylactic anticoagulation
- Compare and contrast medications used in the management of cancer-associated thrombosis
Speaker(s)/Author(s)
Andy Maldonado, PharmD
|